AKEBIA THERAPEUTICS, INC. Accounts Payable
AKEBIA THERAPEUTICS, INC. (AKBA) had Accounts Payable of $9.42 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Payable, Current $9.42M.
- 2026-03-31: Accounts Payable, Current $8.39M.
- 2025-12-31: Accounts Payable, Current $21.18M.
- 2025-09-30: Accounts Payable, Current $10.09M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.42M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $8.39M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $21.18M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $10.09M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $11.55M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $12.66M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $15.18M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $13.49M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $10.11M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $11.88M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $14.63M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $9.04M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $11.78M 10-Q · filed 2023-08-28 | |
| 2023-03-31 | $12.58M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $18.02M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $19.71M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $24.94M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $19.47M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $33.59M 10-K/A · filed 2023-08-28 | |
| 2021-09-30 | $28.81M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $41.98M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $30.54M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $41.31M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $40.40M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $29.41M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $54.38M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $39.22M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $64.36M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $19.32M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $15.23M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $42.80M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $12.68M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $4.79M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $17.88M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $7.00M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $8.71M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $10.21M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $15.08M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.04M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $8.52M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $5.14M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $2.42M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $2.31M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $5.27M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $2.41M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $4.33M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $2.02M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $3.03M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.49M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $2.08M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $714.00K 10-K · filed 2015-03-04 | $714.14K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |